The C5a Anaphylatoxin Receptor CD88 is Expressed in Presynaptic Terminals of Hippocampal Mossy Fibres

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2009 Nov 18

PMID 19917081

Citations 14

Authors

James W Crane

Gilang P Baiquni

Robert Kp Sullivan

John D Lee

Pankaj Sah

Stephen M Taylor

Peter G Noakes

Trent M Woodruff

Affiliations

Soon will be listed here.

Abstract

Background: In the periphery, C5a acts through the G-protein coupled receptor CD88 to enhance/maintain inflammatory responses. In the brain, CD88 can be expressed on astrocytes, microglia and neurons. Previous studies have shown that the hippocampal CA3 region displays CD88-immunolabelling, and CD88 mRNA is present within dentate gyrus granule cells. As granule cells send dense axonal projections (mossy fibres) to CA3 pyramidal neurons, CD88 expression could be expressed on mossy fibres. However, the cellular location of CD88 within the hippocampal CA3 region is unknown.

Methods: The expression of CD88 within the hippocampal CA3 region was characterized using dual-immunolabelling of hippocampal sections prepared from Wistar rats. Immunolabelling for CD88, using a monoclonal antibody, was combined with immunolabelling for markers of astrocytes (GFAP), microglia (IBA1), presynaptic proteins (synaptophysin and synapsin-1) and preterminal axons (neurofilament). In addition, electron microscopy was performed on peroxidase-visualized CD88-immunolabelling to determine its cellular localisation within the CA3 region.

Results: Dense CD88-immunolabelling was observed within the stratum lucidum of the CA3, consistent with the presence of CD88 on mossy fibres. Labelling for CD88 rarely co-localized with astrocytes or microglia, but was highly co-localized with presynaptic proteins. Electron microscopy revealed CD88-immunolabelling was localized to large presynaptic terminals within the stratum lucidum.

Conclusion: These results demonstrate that CD88 is expressed on presynaptic terminals of mossy fibres within the CA3 region of the hippocampus. Although the role of CD88 on mossy fibres remains to be established, their involvement in synaptic/cellular plasticity, and in cognitive disorders such as Alzheimer's disease deserves investigation.

Citing Articles

Epigenetic mechanisms of alveolar macrophage activation in chemical-induced acute lung injury.

Ahmad S, Nasser W, Ahmad A Front Immunol. 2024; 15:1488913.

PMID: 39582870 PMC: 11581858. DOI: 10.3389/fimmu.2024.1488913.

Complement C5a Implication in Axonal Growth After Injury.

Cotten A, Jeanneau C, Decherchi P, About I Cells. 2024; 13(20.

PMID: 39451247 PMC: 11506376. DOI: 10.3390/cells13201729.

Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.

Theophanous S, Sargiannidou I, Kleopa K Int J Mol Sci. 2024; 25(17).

PMID: 39273535 PMC: 11395575. DOI: 10.3390/ijms25179588.

Complement C5a Receptor Signaling Alters Stress Responsiveness and Modulates Microglia Following Chronic Stress Exposure.

Chen H, Spiers J, Lerskiatiphanich T, Parker S, Lavidis N, Fung J Biol Psychiatry Glob Open Sci. 2024; 4(3):100306.

PMID: 38628385 PMC: 11019103. DOI: 10.1016/j.bpsgos.2024.100306.

C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease.

Gomez-Arboledas A, Fonseca M, Kramar E, Chu S, Schartz N, Selvan P Alzheimers Dement. 2024; 20(3):2173-2190.

PMID: 38278523 PMC: 10984438. DOI: 10.1002/alz.13682.

References

Ilschner S, Nolte C, Kettenmann H . Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia. Neuroscience. 1996; 73(4):1109-20. DOI: 10.1016/0306-4522(96)00107-8. View

Farkas I, Takahashi M, Fukuda A, Yamamoto N, Akatsu H, Baranyi L . Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. J Immunol. 2003; 170(11):5764-71. DOI: 10.4049/jimmunol.170.11.5764. View

Mukherjee P, Pasinetti G . The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease. J Neuroimmunol. 2000; 105(2):124-30. DOI: 10.1016/s0165-5728(99)00261-1. View

Sudhof T, Jahn R . Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron. 1991; 6(5):665-77. DOI: 10.1016/0896-6273(91)90165-v. View

Klos A, Tenner A, Johswich K, Ager R, Reis E, Kohl J . The role of the anaphylatoxins in health and disease. Mol Immunol. 2009; 46(14):2753-66. PMC: 2725201. DOI: 10.1016/j.molimm.2009.04.027. View

Blaabjerg M, Zimmer J . The dentate mossy fibers: structural organization, development and plasticity. Prog Brain Res. 2007; 163:85-107. DOI: 10.1016/S0079-6123(07)63005-2. View

Mukherjee P, Pasinetti G . Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem. 2001; 77(1):43-9. DOI: 10.1046/j.1471-4159.2001.00167.x. View

Fonseca M, Ager R, Chu S, Yazan O, Sanderson S, LaFerla F . Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J Immunol. 2009; 183(2):1375-83. PMC: 4067320. DOI: 10.4049/jimmunol.0901005. View

Farkas I, Baranyi L, Liposits Z, Yamamoto T, Okada H . Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience. 1998; 86(3):903-11. DOI: 10.1016/s0306-4522(98)00108-0. View

10.

Guo R, Ward P . Role of C5a in inflammatory responses. Annu Rev Immunol. 2005; 23:821-52. DOI: 10.1146/annurev.immunol.23.021704.115835. View

11.

Sayah S, Patte C, Gasque P, Chan P, Ischenko A, Vaudry H . Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Brain Res Mol Brain Res. 1997; 48(2):215-22. DOI: 10.1016/s0169-328x(97)00094-6. View

12.

Sudhof T . The synaptic vesicle cycle. Annu Rev Neurosci. 2004; 27:509-47. DOI: 10.1146/annurev.neuro.26.041002.131412. View

13.

Rittirsch D, Flierl M, Nadeau B, Day D, Huber-Lang M, Mackay C . Functional roles for C5a receptors in sepsis. Nat Med. 2008; 14(5):551-7. PMC: 2753858. DOI: 10.1038/nm1753. View

14.

Guo R, Riedemann N, Ward P . Role of C5a-C5aR interaction in sepsis. Shock. 2003; 21(1):1-7. DOI: 10.1097/01.shk.0000105502.75189.5e. View

15.

OBarr S, Caguioa J, Gruol D, Perkins G, Ember J, Hugli T . Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol. 2001; 166(6):4154-62. DOI: 10.4049/jimmunol.166.6.4154. View

16.

Ohno M, Hirata T, Enomoto M, Araki T, Ishimaru H, Takahashi T . A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol. 2000; 37(8):407-12. DOI: 10.1016/s0161-5890(00)00067-5. View

17.

Manthey H, Woodruff T, Taylor S, Monk P . Complement component 5a (C5a). Int J Biochem Cell Biol. 2009; 41(11):2114-7. DOI: 10.1016/j.biocel.2009.04.005. View

18.

Farkas I, Varju P, Szabo E, Hrabovszky E, Okada N, Okada H . Estrogen enhances expression of the complement C5a receptor and the C5a-agonist evoked calcium influx in hormone secreting neurons of the hypothalamus. Neurochem Int. 2007; 52(4-5):846-56. DOI: 10.1016/j.neuint.2007.09.014. View

19.

Osaka H, Mukherjee P, Aisen P, Pasinetti G . Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem. 1999; 73(3):303-11. View

20.

Scola A, Johswich K, Morgan B, Klos A, Monk P . The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol. 2008; 46(6):1149-62. PMC: 2697321. DOI: 10.1016/j.molimm.2008.11.001. View